[1]王俞方,刘翀,彭辉灿,等.土槿乙酸对高糖环境下人视网膜微血管内皮细胞表达血管内皮生长因子的影响[J].眼科新进展,2019,39(10):915-919.[doi:10.13389/j.cnki.rao.2019.0208]
　WANG Yu-Fang,LIU Chong,PENG Hui-Can,et al.Pseudolaric acid B down-regulates the expression of vascular endothelial growth factor in human retinal microvascular endothelial cells under high glucose environment[J].Recent Advances in Ophthalmology,2019,39(10):915-919.[doi:10.13389/j.cnki.rao.2019.0208]
点击复制

土槿乙酸对高糖环境下人视网膜微血管内皮细胞表达血管内皮生长因子的影响/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
39卷
期数:
2019年10期
页码:
915-919
栏目:
实验研究
出版日期:
2019-10-05

文章信息/Info

Title:
Pseudolaric acid B down-regulates the expression of vascular endothelial growth factor in human retinal microvascular endothelial cells under high glucose environment
作者:
王俞方; 刘翀; 彭辉灿; 肖启国
421001　湖南省衡阳市，南华大学附属第二医院眼科
Author(s):
WANG Yu-Fang; LIU Chong; PENG Hui-Can; XIAO Qi-Guo
Department of Ophthalmology，the Second Hospital of South China University，Hengyang 421001，Hunan Province，China
关键词:
增生性糖尿病视网膜病变; 土槿乙酸; 血管内皮生长因子
Keywords:
proliferative diabetic retinopathy; pseudolaric acid B; vascular endothelial growth factor
分类号:
R774
DOI:
10.13389/j.cnki.rao.2019.0208
文献标志码:
A
摘要:
目的　观察土槿乙酸对高糖环境下人视网膜微血管内皮细胞（human retinal microvascular endothelial cells，HRMEC）表达血管内皮生长因子（vascular endothelial growth factor，VEGF）的影响。方法　体外培养HRMEC，根据不同的实验目的将其分为低糖空白对照（PL）组、土槿乙酸对照（P0）组、高糖对照（PH）组以及不同浓度土槿乙酸+高糖（P1、P2、P3）组。采用MTT法检测土槿乙酸作用后HRMEC的增殖情况，实时定量PCR和Western blot检测VEGF的mRNA和蛋白表达以及核转录因子FOXO3a的磷酸化，免疫荧光检测FOXO3a的核转位，染色质共沉淀检测FOXO3a和VEGF启动子的结合。结果　PH组HRMEC增殖率和VEGF表达水平明显高于PL组，并且随着时间的延长，HRMEC增殖率和VEGF表达均逐渐增高（均为P<0.05）；而经不同浓度土槿乙酸处理后的P1组、P2组和P3组中的HRMEC增殖率及VEGF表达水平与PH组相比，差异也均有统计学意义（均为P＜0.05）。Western blot结果显示，P0组HRMEC中FOXO3a磷酸化水平较低，PL组和PH组均有不同程度增高，而P1、P2、P3组随着土槿乙酸浓度的增加，FOXO3a磷酸化水平随之降低。免疫荧光和染色质共沉淀结果显示，P0组HRMEC中FOXO3a在细胞核内含量较多，和VEGF启动子的结合水平较高；而在PL组和PH组，细胞浆中FOXO3a明显增多，核内FOXO3a和VEGF的结合水平低于P0组；P1组、P2组及P3组中细胞核内FOXO3a以及FOXO3a-VEGF DNA复合体明显增多。结论　土槿乙酸能抑制高糖条件下HRMEC的增殖，最终激活核转录因子FOXO3a，从而下调HRMEC表达VEGF。
Abstract:
Objective　To observe the effect of pseudolaric acid B on the expression of vascular endothelial growth factor (VEGF) in human retinal microvascular endothelial cells under high glucose environment.Methods　Human retinal microvascular endothelial cells (HRMECs) were cultured in vitro and divided into low-glucose blank control group (PL group),pseudolaric acid B group (P0 group),high-glucose control group (PH group),high-glucose plus different concentration of pseudolaric acid B group (P1,P2,P3 group) according to the experimental purposes.MTT assay was used to detect the proliferation of pseudolaric acid B-treated cells.Real-time quantitative PCR and Western blot were used to detect the expression of VEGF and phosphorylation of the transcription factor FOXO3a.Immunofluorescence was used to detect the nuclear translocation of FOXO3a.Chromatin coprecipitation was used to detect the binding of FOXO3a to the promoter of VEGF.Results　The cell proliferation rate and the expression level of VEGF in PH group were significantly higher than those in PL group,and the cell proliferation rate and the expression level of VEGF increased gradually with the prolongation of time (both P<0.05),while the cell proliferation rate and the level of VEGF in P1,P2 and P3 groups were significantly higher than those in PH group (all P<0.05).Western blot results showed that the phosphorylation level of FOXO3a was lower in P0 group,but PL and PH groups had higher phosphorylation level of FOXO3a.The phosphorylation level of FOXO3a in P1,P2,P3 groups decreased with the increase of pseudolaric acid B concentration.Immunofluorescence and chromatin co-precipitation results also showed that FOXO3a in the P0 group was more abundant in the nucleus and the binding level of FOXO3a to VEGF was high.In PL and PH groups,the cytoplasmic FOXO3a increased significantly,and the binding level of FOXO3a to VEGF in nucleus was lower than that in the P0 group,but increased significantly in the P1,P2,P3 groups.Conclusion　Pseudolaric acid B can inhibit the proliferation of HRCECs grown under high glucose environment,and ultimately activate nuclear transcription factor FOXO3a,thereby down-regulating the expression of VEGF.

参考文献/References:

［1］　HA M，CHOI S Y，KIM M，NA J K，PARK Y H.Diabetic nephropathy in type 2 diabetic retinopathy requiring panretinal photocoagulation［J］.Korean J Ophthalmol，2019，33（1）：46-53.
［2］　CHOI H S，KIM Y K，PARK S P.Choroidal osteoma accompanied by proliferative diabetic retinopathy［J］.Korean J Ophthalmol，2018，32（6）：521-522.
［3］　MESSIAS K，BARROSO R M，JORGE R，MESSIAS A.Retinal function in eyes with proliferative diabetic retinopathy treated with intravitreal ranibizumab and multispot laser panretinal photocoagulation［J］.Doc Ophthalmol，2018，137（2）：121-129.
［4］　LIM J I，SPEE C，HINTON D R.A comparison of hypoxia-inducible factor-α in surgically excised neovascular membranes of patients with diabetes compared with idiopathic epiretinal membranes in nondiabetic patients［J］.Retina，2010，30（9）：1472-1478.
［5］　PALANISAMY K，NARESHKUMAR R N，SIVAGURUNATHAN S，RAMAN R，SULOCHANA K N，CHIDAMBARAM S.Anti-angiogenic effect of adiponectin in human primary microvascular and macrovascular endothelial cells［J］.Microvasc Res，2019，122(2)：136-145.
［6］　LIU M L，SUN D，LI T，CHEN H.A systematic review of the immune-regulating and anticancer activities of pseudolaric acid B［J］.Front Pharmacol，2017，8：394.
［7］　DUFFY A，LIEW A，O’SULLIVAN J，AVALOS G，SAMALI A，O’BRIEN T.Distinct effects of high-glucose conditions on endothelial cells of macrovascular and microvascular origins［J］.Endothelium，2006，13（1）：9-16.
［8］　LI M H，MIAO Z H，TAN W F，YUE J M，ZHANG C，LIN L P，et al.Pseudolaric acid B inhibits angiogenesis and reduces hypoxia-inducible factor 1alpha by promoting proteasome-mediated degradation［J］.Clin Cancer Res，2004，10（24）：8266-8274.
［9］　LIU Y，AO X，DING W，PONNUSAMY M，WU W，HAO X，et al.Critical role of FOXO3a in carcinogenesis［J］.Mol Cancer，2018，17（1）：104.
［10］　CHIACCHIERA F，SIMONE C.The AMPK-FoxO3A axis as a target for cancer treatment［J］.Cell Cycle，2010，9（6）：1091-1096.
［11］　FINNBERG N，EL-DEIRY W S.Activating FOXO3a，NF-kappa B and p53 by targeting IKKs：an effective multi-faceted targeting of the tumor-cell phenotype?［J］.Cancer Biol Ther，2004，3（7）：614-616.
［12］　LU H，ZHANG L H，YANG L，TANG P F.The PI3K/Akt/FOXO3a pathway regulates regeneration following spinal cord injury in adult rats through TNF-α and p27kip1 expression［J］.Int J Mol Med，2018，41（5）：2832-2838.
［13］　SHANKAR S，MARSH L，SRIVASTAVA R K.EGCG inhibits growth of human pancreatic tumors orthotopically implanted in Balb C nude mice through modulation of FKHRL1/FOXO3a and neuropilin［J］.Mol Cell Biochem，2013，372（1-2）：83-94.

相似文献/References:

[1]董敬远 刘瑶 吴晓艳.玻璃体切割联合白内障手术治疗增生性糖尿病视网膜病变[J].眼科新进展,2012,32(5):000.
[2]刘敬花 李松峰 卢海.23G微创玻璃体切割术在增生性糖尿病视网膜病变治疗中的应用[J].眼科新进展,2012,32(11):000.
[3]王丁丁 陈子林 周慧兰 宋青山.重硅油填充治疗增生性糖尿病视网膜病变的临床研究[J].眼科新进展,2013,33(1):000.
[4]陈明 蔡小军 胡梅 张启明 王永力.玻璃体切割联合超声乳化人工晶状体植入术治疗白内障合并PDR临床分析[J].眼科新进展,2013,33(9):000.
[5]张英楠 陈晓隆.玻璃体切割术治疗增生性糖尿病视网膜病变的临床疗效分析[J].眼科新进展,2012,32(1):000.
[6]罗毅,梅海峰.微创玻璃体切割联合超声乳化术治疗增生性糖尿病视网膜病变的疗效观察[J].眼科新进展,2014,34(6):577.[doi:10.13389/j.cnki.rao.2014.0159]
[7]蒋乐文,曹燕. 玻璃体切割术对增生性糖尿病视网膜病变患者黄斑区视网膜的影响[J].眼科新进展,2014,34(7):672.[doi:10.13389/j.cnki.rao.2014.0184]
[8]章晖,叶波,邱新文,等.雷珠单抗辅助23G玻璃体切割术治疗增生性糖尿病视网膜病变[J].眼科新进展,2014,34(10):975.[doi:10.13389/j.cnki.rao.2014.0270]
[9]詹冬梅,史琴,哈玲芳,等. 两种联合术式人工晶状体植入术治疗增生性糖尿病视网膜病变的对比研究[J].眼科新进展,2015,35(3):266.[doi:10.13389/j.cnki.rao.2015.0071]
　ZHAN Dong-Mei,SHI Qin,HA Ling-Fang,et al. Comparative study of vitrectomy combined with phacoemulsification or pars plana lensectomy for proliferative diabetic retinopathy[J].Recent Advances in Ophthalmology,2015,35(10):266.[doi:10.13389/j.cnki.rao.2015.0071]
[10]时倩倩,刘华,付蓉花. 全视网膜光凝术对增生性糖尿病视网膜病变患者黄斑区视网膜功能的影响[J].眼科新进展,2015,35(4):362.[doi:10.13389/j.cnki.rao.2015.0097]
　SHI Qian-Qian,LIU Hua,FU Rong-Hua. Effects of panretinal photocoagulation on macular retina of patients with proliferative diabetic retinopathy[J].Recent Advances in Ophthalmology,2015,35(10):362.[doi:10.13389/j.cnki.rao.2015.0097]

备注/Memo

备注/Memo:
湖南省卫生计生委科研计划课题（编号：B2017058）
更新日期/Last Update: 2019-10-12